scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.1780150109 |
P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780150109 |
https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780150109 | ||
P698 | PubMed publication ID | 5059643 |
P2093 | author name string | F. Bishko | |
P2860 | cites work | Ocular changes in acute systemic lupus erythematosus | Q34247120 |
Oral Contraceptives and Neuro-Ophthalmologic Interest | Q40028735 | ||
Antinuclear antibodies: Diagnostic significance and methods | Q40045432 | ||
Immunofluorescent Techniques in Clinical Diagnosis of Cutaneous Disease | Q47784389 | ||
THREE CASES OF INTRAVASCULAR THROMBOSIS OCCURRING IN PATIENTS RECEIVING ORAL CONTRACEPTIVES. | Q55100302 | ||
Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus | Q70064767 | ||
Natural history of lupus erythematosus disseminatus | Q73091383 | ||
The effect of the L. E. cell test on the clinical picture of systemic lupus erythematosus | Q73195264 | ||
SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS | Q76936822 | ||
Relation of Positive L.E.-Cell Preparations to Activity of Lupus Erythematosus and Corticosteroid Therapy | Q79066249 | ||
Folia Ophthalmologica Japonica | Q96327614 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
rheumatology | Q327657 | ||
immunology | Q101929 | ||
P304 | page(s) | 57-63 | |
P577 | publication date | 1972-01-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
Arthritis and Rheumatism | Q23929027 | ||
P1476 | title | Retinopathy in systemic lupus erythematosus. A case report and review of the literature | |
P478 | volume | 15 |
Q33561648 | Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome |
Q40602155 | Central retinal vein occlusion and cerebellar infarction complicating systemic lupus erythematosus: a case report |
Q39831064 | Cerebral disease in systemic lupus erythematosus |
Q33647566 | Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings |
Q34489089 | Hydralazine induced lupus syndrome with eye disease. |
Q33645166 | Immunological abnormalities in patients with untreated retinal vasculitis |
Q67290871 | Lupus erythematosus |
Q72496029 | Neurological complications of connective tissue and other “collagen-vascular” diseases |
Q70292559 | Optic neuritis and myelopathy in systemic lupus erythematosus |
Q66964470 | Retinal Microangiopathy in Systemic Lupus Erythematosus |
Q93655749 | Retinal vasculitis associated with autoantibodies to Sjögren's syndrome A antigen |
Q33553950 | SLE retinopathy: evaluation by fluorescein angiography |
Q69388776 | Severe retinal vaso-occlusive disease secondary to procainamide-induced lupus |
Q66980031 | The neuro-ophthalmology of systemic lupus erythematosus |
Q69649363 | Unusual eye manifestations in systemic lupus erythematosus patients |
Q44583525 | Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). |
Q70896386 | Visual Loss as the Initial Symptom of Systemic Lupus Erythematosus |
Search more.